XML 388 R67.htm IDEA: XBRL DOCUMENT v3.25.0.1
DISCONTINUED OPERATIONS - Narrative (Details) - RX Pharmaceuticals - Discontinued Operations, Disposed of by Sale
$ in Millions
Jul. 06, 2021
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Total consideration in definitive agreement to sell $ 1,550.0
Potential R&D milestone payments and contingent purchase obligations assumed by purchaser $ 53.3
Supply agreement term 4 years
Supply agreement, extension period 7 years
Aggregate cap on buyer's obligation for certain pre-closing liabilities (percent) 50.00%
Aggregate cap on buyer's obligation for certain pre-closing liabilities $ 50.0